GenVec gene therapy shows promising phase I results in patients with severe coronary artery disease Aug. 6, 1999
Third-generation beta-blocker with vasorelaxant and alpha-adrenoceptor-blocking effects July 30, 1999
Inhibitors of 15-LO designed at Warner-Lambert, particularly useful for atherosclerosis July 30, 1999
RSS